IL MARATONETA
Forumer storico
ad acquistare?
Obbligazioni societarie HIGH YIELD e oltre, verso frontiere inesplorate - Vol. 2 (4 lettori)
- Creatore Discussione gionmorg
- Data di Inizio
IL MARATONETA
Forumer storico
Trovata la risposta, comunque prezzo molto basso
IL MARATONETA
Forumer storico
In tutto 18k$ per cedolare.
waltermasoni
Caribbean Trader
Fitch Downgrades thyssenkrupp to 'BB-'; Outlook Stable
04 MAR 2020 11:43 AM ET
04 MAR 2020 11:43 AM ET
waltermasoni
Caribbean Trader
Fitch Affirms Teva at 'BB-'; Outlook Remains Negative
04 MAR 2020 10:00 AM ET
Fitch Ratings - New York - 04 March 2020:
Fitch Ratings has affirmed Teva Pharmaceutical Industries Limited's (Teva) ratings, including the company's Long-Term Issuer Default Rating (IDR), at 'BB-'. The Rating Outlook is Negative.
The ratings reflect the company's substantial indebtedness and modest financial flexibility. The Negative Outlook is heavily influenced by the lack of resolution to the company's litigation profile.
Partially offsetting these risk factors, Fitch believes Teva's credit profile has been enhanced as a result of its comprehensive cost and business restructuring activities. Those activities have included several steps, including optimization of the global generics portfolio through either product discontinuation or price adjustments. The Rating Outlook could be revised to Stable upon resolution of the litigation profile within the boundaries of Fitch's current ratings case for the issuer, which would give increased certainty that the company has the necessary financial flexibility to repay debt and reduce leverage without constraining R&D spending and investment in future growth opportunities.
04 MAR 2020 10:00 AM ET
Fitch Ratings - New York - 04 March 2020:
Fitch Ratings has affirmed Teva Pharmaceutical Industries Limited's (Teva) ratings, including the company's Long-Term Issuer Default Rating (IDR), at 'BB-'. The Rating Outlook is Negative.
The ratings reflect the company's substantial indebtedness and modest financial flexibility. The Negative Outlook is heavily influenced by the lack of resolution to the company's litigation profile.
Partially offsetting these risk factors, Fitch believes Teva's credit profile has been enhanced as a result of its comprehensive cost and business restructuring activities. Those activities have included several steps, including optimization of the global generics portfolio through either product discontinuation or price adjustments. The Rating Outlook could be revised to Stable upon resolution of the litigation profile within the boundaries of Fitch's current ratings case for the issuer, which would give increased certainty that the company has the necessary financial flexibility to repay debt and reduce leverage without constraining R&D spending and investment in future growth opportunities.
hernan1
Forumer attivo
Pagano 100,4 non 104
apudmontem
Forumer storico
Se può essere utile, a dipanare qualche tuo dubbio, sotto ho fatto copia/incolla di parte della comunicazione inviatami dalla mia banca, a suo tempo:
Le comunichiamo che, ai sensi del piano di riorganizzazione Joint Chapter 11 delle Legacy Reserves Inc (ISIN US52471TAB35), gli obbligazionisti previa registrazione al trasfer agent (“Broadridge Investor Solutions”), hanno diritto a ricevere delle nuove obbligazioni in concambio. Le nuove obbligazioni non sono DTC eligible e non possono essere detenute sul nostro sistema di clearing (Clearstream). In seguito a tale registrazione, gli obbligazionisti riceveranno successive informazioni direttamente dal trasfer agent.
Per ricevere le nuove Equity, è necessario che gli aventi diritto compilino ed inviino, contestualmente alle istruzioni ed al W-8BEN allegato, l’ “Account Registration Instruction Sheet” anch’esso allegato alla presente.
Sarò stolto io, ma non sono riuscito a registrarmi..
fabriziof
Forumer storico
Inviino a chi?